Patients infected with human immunodeficiency virus (HIV) and/or hepatitis C virus (HCV) or hepatitis B virus (HBV) have traditionally been considered high-risk recipients for transplantation. Recent advances have had a significant effect on the potential transplant candidacy of these patients. This review highlights the major issues associated with cardiothoracic transplantation in individuals who are infected with HIV and/or HCV
Abstract: HIV-hepatitis C virus(HCV) coinfection is common and affects more than one-third of all HI...
HCC is the leading cause of death aong patients with cirrhosis. HIV positive patients are likely to ...
Well into the 25th year of the HIV pandemics, and into the 15th year of the highly active antiretrov...
Patients infected with human immunodeficiency virus (HIV) and/or hepatitis C virus (HCV) or hepatiti...
Multiple strategies have been implemented to increase the donor pool to avoid transplant wait-list m...
Cardiovascular diseases have become a significant cause of morbidity in patients with human immunode...
Hepatitis viruses B (HBV), C (HCV) and D (HDV) and the retroviruses human immunodeficiency virus (HI...
Terrault et al prospectively described a series of human immunodeficiency virus (HIV)–infected pati...
Purpose of reviewTo review the experience to date and unique challenges associated with liver transp...
The advent of therapies for successful treatment of hepatitis C virus has allowed the heart and lung...
Despite significant advances in transplantation of HIV-infected individuals, little is known about H...
BACKGROUND: Heart transplant (HTx) recipients risk acquiring hepatotropic viral infections such as ...
Morbidity and mortality of HIV-infected patients have been improved over the last decades with the a...
The purpose of this study was to assess the safety and the clinical outcome associated with organ tr...
: Organ transplantation is a life-saving treatment for patients with end-stage organ disease, a seve...
Abstract: HIV-hepatitis C virus(HCV) coinfection is common and affects more than one-third of all HI...
HCC is the leading cause of death aong patients with cirrhosis. HIV positive patients are likely to ...
Well into the 25th year of the HIV pandemics, and into the 15th year of the highly active antiretrov...
Patients infected with human immunodeficiency virus (HIV) and/or hepatitis C virus (HCV) or hepatiti...
Multiple strategies have been implemented to increase the donor pool to avoid transplant wait-list m...
Cardiovascular diseases have become a significant cause of morbidity in patients with human immunode...
Hepatitis viruses B (HBV), C (HCV) and D (HDV) and the retroviruses human immunodeficiency virus (HI...
Terrault et al prospectively described a series of human immunodeficiency virus (HIV)–infected pati...
Purpose of reviewTo review the experience to date and unique challenges associated with liver transp...
The advent of therapies for successful treatment of hepatitis C virus has allowed the heart and lung...
Despite significant advances in transplantation of HIV-infected individuals, little is known about H...
BACKGROUND: Heart transplant (HTx) recipients risk acquiring hepatotropic viral infections such as ...
Morbidity and mortality of HIV-infected patients have been improved over the last decades with the a...
The purpose of this study was to assess the safety and the clinical outcome associated with organ tr...
: Organ transplantation is a life-saving treatment for patients with end-stage organ disease, a seve...
Abstract: HIV-hepatitis C virus(HCV) coinfection is common and affects more than one-third of all HI...
HCC is the leading cause of death aong patients with cirrhosis. HIV positive patients are likely to ...
Well into the 25th year of the HIV pandemics, and into the 15th year of the highly active antiretrov...